Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Caficrestat by Applied Therapeutics for Cardiomyopathy: Likelihood of Approval
Caficrestat is under clinical development by Applied Therapeutics and currently in Phase III for Cardiomyopathy. According to GlobalData, Phase III...
Gavorestat by Applied Therapeutics for Galactosemia: Likelihood of Approval
Gavorestat is under clinical development by Applied Therapeutics and currently in Pre-Registration for Galactosemia. According to GlobalData, Pre-Registration drugs for...
Risk adjusted net present value: What is the current valuation of Applied Therapeutics's Gavorestat?
Gavorestat is a small molecule commercialized by Applied Therapeutics, with a leading Pre-Registration program in Galactosemia. According to Globaldata, it...